Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue July 2014
 •  Pilot Launches New Site  •  Nu Skin Marks 30th Anniversary  •  Eileen Ford, Dead at 92  •  Birchbox Goes Brick-and-Mortar  •  Galderma Gains Full Rights To Distribute Restylane
Print

Fungal Treatment



Published March 9, 2006
Related Searches: patent active skin
Post a comment
Patent No. US 6,986,896 B2: Bradley Pharmaceuticals, Inc., Fairfield, NJ, patented a method for treating fungal skin conditions. The fungal condition is Tinea pedis, a condition caused by a dermatophyte, a trichophyton, an epidermophyton and Candida Albicans. The product consists of urea as the sole active ingredient and a dermatologically acceptable excipient.


blog comments powered by Disqus